traA Antibody

Basic Research Questions

• What is traA protein and why is it significant in scientific research?

TraA is a pilin protein found in type IV secretion systems (T4SS), particularly well-studied in Neisseria gonorrhoeae within the gonococcal genetic island (GGI). The protein undergoes complex processing to form a 68-amino acid circular peptide through the coordinated action of leader peptidase and TrbI (a serine protease homologous to TraF in RP4 plasmid) .

• What methodological approaches should be considered when using traA antibodies in experimental design?

When designing experiments with traA antibodies, researchers should consider:

Membrane preparation techniques: TraA is membrane-inserted, requiring appropriate solubilization methods. In vitro assays with solubilized membranes may require detergents like Triton X-100 which can affect antibody binding .

Controls: Include pre-immune serum (negative control) and recombinant immunogen protein (positive control) as provided in commercial antibody kits .

Fixation and processing impact: The antibody's detection capability can be significantly affected by sample processing methods. For membrane proteins like TraA, traditional fixation methods may mask epitopes .

Application-specific considerations:

• How can researchers distinguish between processed and unprocessed forms of TraA protein?

Distinguishing between TraA processing states requires specific methodological approaches:

Gel electrophoresis resolution: Use 17% polyacrylamide SDS-PAGE gels to achieve separation between the different processed forms of TraA .

Antibody epitope selection: The TraA antibody should target a region preserved in both processed and unprocessed forms. For example, in N. gonorrhoeae research, antibodies were raised against the specific antigen sequence "TGAEFKGLADMVTGC" .

Visualization approaches: Immunoblotting can identify different TraA forms with triangles indicating positions of leader peptidase-cleaved (gray) and other processed forms. For radioactive detection, S35-labeled TraA synthesis allows tracking through autoradiography or phosphorimaging .

Processing markers: The circularization of TraA involves removal of three C-terminal amino acids. To identify this form, researchers can analyze migration patterns that distinguish between linear and circular peptides, which often show different electrophoretic mobility .

• What controls should be included when working with traA antibodies?

Effective controls are essential for traA antibody experiments:

Negative controls:

• Pre-immune serum from the host animal (typically provided with commercial antibodies)

• Isotype control antibody of matching class (IgG for polyclonal TraA antibodies)

• Host cells lacking the GGI region (such as N. gonorrhoeae strain ND500)

Positive controls:

• Recombinant TraA protein/peptide (200μg typically included with commercial antibodies)

• Strains with confirmed TraA expression (such as MS11 or SJ015-MS)

• In-vitro translated TraA protein

Experimental reference samples:

• Membrane fractions from TraA-expressing bacteria

• Solubilized membrane preparations with and without detergent treatment

• Serial dilutions for establishing detection limits

For accurate protein quantification after lysis, use Lowry detergent compatible assay .

• How does sample preparation affect traA antibody detection sensitivity?

Sample preparation critically influences traA antibody detection:

Membrane protein extraction: TraA is membrane-associated and requires specialized extraction protocols. Use radioimmunoprecipitation assay (RIPA) buffer supplemented with protease inhibitors and sodium orthovanadate to preserve protein integrity .

Cell lysis optimization: Sonication on ice (15 seconds × 2) followed by centrifugation at 14,000 rpm for 2 minutes provides optimal extraction while preventing protein degradation .

Protein stabilization: TraA is sensitive to degradation; samples should be preserved with 50% glycerol and 0.03% Proclin 300 in 0.01M PBS at pH 7.4 .

Storage considerations: Store antibodies at -20°C or -80°C for long-term stability . For extracted proteins or cells expressing TraA, immediate processing yields better results than freeze-thaw cycles.

Detection enhancement: For low abundance TraA, signal amplification methods such as alkaline phosphatase-conjugated secondary antibodies (1:20,000 dilution) can improve sensitivity .